Strategies to Improve Asthma and Treatment of Asthma in Canadians
NCT ID: NCT01525381
Last Updated: 2016-03-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
701 participants
OBSERVATIONAL
2011-11-30
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diagnosing Asthma With Clinically Accessible, Non-invasive, and Efficient Tests: a Child-inclusive Translational Investigation
NCT07011394
International Severe Asthma Registry: Canadian Cohort
NCT04045587
Phenotyping Disease Severity in Asthma
NCT05078021
Measurements of Inflammation Induced by Allergen Inhalation Challenge in Mild Allergic Asthma
NCT06411886
Develop and Implement Asthma Controlling Strategies
NCT00005731
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patient must be at least 18 years old.
Exclusion Criteria
* Patients using chronic oral prednisone.
* Patients with heart attack or stroke within three previous months, and those with known aortic or cerebral aneurysms.
* Pregnant patients (unknown effect of methacholine on the fetus) and breastfeeding patients (unknown whether methacholine is excreted in breast milk).
2. Patients unable to provide informed consent.
3. Patients not able to perform spirometry and/or methacholine challenge testing.
4. Patients who have a greater than 10 pack-year smoking history (this will exclude patients with possible COPD).
5. Patients who currently have active pulmonary Tuberculosis
6. Patients who have had eye surgery in the past 3 months or who have a detached retina
7. Patients involved in another interventional asthma study
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ottawa Hospital Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shawn Aaron, MD
Role: PRINCIPAL_INVESTIGATOR
Ottawa Hosptial Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ottawa Hospital
Ottawa, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-221
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.